USPTO serial 79400910
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel M. Gurfinkel
Daniel M. Gurfinkel Dennemeyer & Associates, LLC.230 West Monroe Street, Suite 2100Chicago, IL 60606United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Adjuvants for medical purposes; Medicinal healthcare preparations, namely, for the treatment of heavy metal detox, vaginal infections, inhalation allergies, pain, insomnia, hormonal disorders; Sanitary preparations for medical use; Food supplements; Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Nutritional supplements; Vitamin supplements; Protein supplements; Diagnostic preparations for medical or veterinary purposes; Pharmaceuticals for the treatment of erectile dysfunction; Vitamins and vitamin preparations; quantum-medical preparations and bio-cybernetic pharmaceutical preparations for the treatment of heavy metal detox, vaginal infections, inhalation allergies, pain, insomnia, hormonal disorders and for hormonal system regulation; Medical preparations for slimming purposes; Nasal spray preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Anti-inflammatory preparations; Pharmaceutical preparations for suppressing tumors; tumor suppressing agents; Pharmaceutical preparations for the treatment of viral diseases; Vaginal moisturizers; Vaginal lubricants; Vaginal antifungals; Vaginal washes for medical purposes; Vaginal suppositories for the prevention and treatment of infections | ACTIVE | — |
| 042 | Research in the field of quantum physics and quantum chemistry; Research in the field of quantum communication technology; Research and development in the medical and biotechnology fields; Research and development in the medical field for pain treatment; Consulting services in the field of biotechnology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Research in the field of bio-cybernetic regulators; custom design of quantum electromagnetic transformers; custom design of quantum electromagnetic inductors; custom design of quantum electromagnetic transformers and electromagnetic inductors for pain treatment; Technical consultancy in relation to technical research in the field of food and beverages; Cosmetic research; Scientific research relating to cosmetics; resarch laboratory analysis in the field of cosmetics; Testing of cosmetics | ACTIVE | — |
| 044 | Performing bio-cybernetic diagnosis of diseases; Health care services, namely, bio-cybernetics therapy; medical services; Performing diagnosis of diseases using quantum-mechanics; medical treatment using quantum-chemical and quantum-physical technology; Regenerative medicine services; Alternative medicine services; Health assessment services; Providing nutritional information about food; Consulting services in the fields of health and nutrition | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 5, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 24, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 24, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 5, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 18, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 18, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 25, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 24, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 24, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 5, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 5, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 16, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 27, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 27, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 27, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 27, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 27, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 24, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 24, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 24, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 20, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 20, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 10, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 9, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 7, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 7, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 25, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |